Home > Resources > Company Profiles > Momenta Pharmaceuticals Inc

Momenta Pharmaceuticals Inc (MNTA)

PRINT
SHARE
TEXT SIZE:
Send a copy to me

Separate multiple email addresses (max 20) with commas.

0/1500
Letters are not case-sensitive, disregard spaces.
captcha image
Try a New One
This helps us prevent automated registrations and spamming.
Craig A. Wheeler , President/Director/CEO
Industry: Healthcare
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME


Overview
News
People
Financials

Company Information

Craig A. Wheeler, President/Director/CEO

675 West Kendall Street

Cambridge, MA 02142

US Map it

Phone: (617) 491-9700

Fax: (617) 621-0431

www.momentapharma.com



Overview

A biotechnology company, specializing in the structural analysis of complex mixture drugs, applying its technology to the development of generic or follow-on versions of complex drug products as well as to the discovery and development of novel drugs.

News From Around the Web
News
powered by inform

Employees

Number of Employees: 163
Revenue per Employee: $101,954

Top Executives

Dr. John E. Bishop, Ph.D., Divisional Senior VP
Steven B. Brugger, COO
Richard P. Shea, CFO/Senior VP

Dr. Ganesh Venkataraman, Ph.D., Divisional Senior VP/Founder/Chief Scientific Officer
Dr. James M. Roach, M.D, Senior VP, Divisional/Chief Medical Officer
Lisa Carron Shmerling, Esq., Divisional Vice President/Secretary

Board of Directors

Peter Barton Hutt, Director
Dr. Ram Sasisekharan, Ph.D., Founder/Director
Dr. Peter Barrett, Ph.D., Chairman of the Board/Director

John K. Clarke, Director
Lisa Carron Shmerling, Esq., Divisional Vice President/Secretary

Financials

Quarterly
Annual

Income Statement 05/2008 02/2008 11/2007 08/2007
Sales NA NA -4.37 Mil. 809 K.
Gross Operating Profit 4.15 Mil. 10 Mil. 9.52 Mil. 3.37 Mil.
Operating Income before D & A (EBITDA) -14.54 Mil. -15.85 Mil. -16.28 Mil. -21.63 Mil.
Total Income Before Interest Expenses (EBIT) -13.34 Mil. -14.29 Mil. -18.65 Mil. -18.58 Mil.
Total Net Income -13.34 Mil. -14.29 Mil. -18.87 Mil. -18.76 Mil.
Basic EPS, Total -0.37 -0.4 -0.53 -0.53
Diluted EPS, Total -0.37 -0.4 -0.53 -0.53

BALANCE STATEMENT 05/2008 02/2008 11/2007 08/2007
Cash and Equivalents 123.56 Mil. 135.94 Mil. 18.31 Mil. 15.96 Mil.
Total Assets NA NA 149.87 Mil. 167.27 Mil.
Total Liabilities 14.93 Mil. 22.41 Mil. 19.23 Mil. 18.4 Mil.
Total Capitalization 116.54 Mil. 127.54 Mil. 138.74 Mil. 154.61 Mil.

Cash Flow 05/2008 02/2008 11/2007 08/2007
Net Cash From Continuing Operations NA NA -47.25 Mil. -28.38 Mil.
Net Cash From Investing Activities NA NA 40.37 Mil. 20.4 Mil.
Net Cash From Financing Activities NA NA 2.84 Mil. 1.6 Mil.
Net Change in Cash & Cash Equivalents NA NA -4.04 Mil. -6.39 Mil.

powered by Interactive Data

Income Statement 2008 2007 2006 2005
Sales NA -245 K. -2.02 Mil. -1.54 Mil.
Gross Operating Profit 21.56 Mil. 16.24 Mil. 16.5 Mil. 9.37 Mil.
Operating Income before D & A (EBITDA) -76.56 Mil. -59.14 Mil. -22.74 Mil. -13.1 Mil.
Total Income Before Interest Expenses (EBIT) -68.88 Mil. -51.41 Mil. -21.4 Mil. -14.04 Mil.
Total Net Income -68.88 Mil. -51.91 Mil. -21.66 Mil. -14.08 Mil.
Basic EPS, Total -1.93 -1.62 -0.79 -2.56
Diluted EPS, Total -1.93 -1.62 -0.79 -2.56

BALANCE STATEMENT 2008 2007 2006 2005
Cash and Equivalents 135.94 Mil. 22.35 Mil. 25.89 Mil. 11.68 Mil.
Total Assets NA 198.06 Mil. 163.4 Mil. 60.12 Mil.
Total Liabilities 22.41 Mil. 12.76 Mil. 7.74 Mil. 5.96 Mil.
Total Capitalization 127.54 Mil. 183.33 Mil. 163.15 Mil. 58.1 Mil.

Cash Flow 2008 2007 2006 2005
Net Cash From Continuing Operations NA -25.21 Mil. -17.02 Mil. -12.55 Mil.
Net Cash From Investing Activities NA -46.34 Mil. -93.28 Mil. -37.25 Mil.
Net Cash From Financing Activities NA 68.02 Mil. 124.51 Mil. 56.86 Mil.
Net Change in Cash & Cash Equivalents NA -3.54 Mil. 14.21 Mil. 7.06 Mil.

powered by Interactive Data





Related Companies by Market Cap
Company Name
Price
Change
Market Cap
Molecular Insight Pharmaceuticals, Incorporated
216.8 Mil.
Nabi Pharmaceuticals
215.89 Mil.
Protalix BioTherapeutics, Incorporated
227.06 Mil.
Emergent BioSolutions, Incorporated
212.12 Mil.

Company Profile Change Request

The data provided in our company profiles comes from third party information providers.

  • If you have a change request regarding a publicly traded company, click here
  • If your request pertains to a private company, click here
Also in Portfolio.com
Most Emailed
Recently Commented